Citation 59020

ARMSTRONG,WB: KENNEDY,AR: WAN,XS: TAYLOR,TH: NGUYEN,QA: JENSEN,J: THOMPSON,W: LAGERBERG,W: MEYSKENS JR,FL:. (2000). CLINICAL MODULATION OF ORAL LEUKOPLAKIA AND PROTEASE ACTIVITY BY BOWMAN-BIRK INHIBITOR CONCENTRATE IN A PHASE IIA CHEMOPREVENTION TRIAL.. 6(12)

Citation Details

TitleCLINICAL MODULATION OF ORAL LEUKOPLAKIA AND PROTEASE ACTIVITY BY BOWMAN-BIRK INHIBITOR CONCENTRATE IN A PHASE IIA CHEMOPREVENTION TRIAL.
AuthorsARMSTRONG,WB: KENNEDY,AR: WAN,XS: TAYLOR,TH: NGUYEN,QA: JENSEN,J: THOMPSON,W: LAGERBERG,W: MEYSKENS JR,FL:
Year2000
Volume6
Issue12

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
TOXIC EFFECT(GENERAL)
INACTIVE
2
ANTITUMOR ACTIVITY
INACTIVE